Direct comparison
Semaglutid vs Cagrilintid
How Semaglutid and Cagrilintid compare on mechanism, evidence and legal status — factual, no recommendations.
| Semaglutid | Cagrilintid | |
|---|---|---|
| Class | GLP-1 analog | Amylin analog |
| Evidence level | clinically established | early clinical studies |
| Legal status (DE) | prescription-only | not approved |
| WADA-listed | No | No |
| Molar mass | 4113.58 Da | 4409 Da |
| Studies cited | 3 | 2 |
| Research areas | Metabolism | Metabolism |
Semaglutid
Semaglutide is a synthetic analog of the body's own incretin hormone GLP-1 (glucagon-like peptide-1).
Full Semaglutid profileCagrilintid
Cagrilintide is a long-acting analog of the hormone amylin, which is co-secreted with insulin by the beta cells of the pancreas.
Full Cagrilintid profileImportant notice
This site is intended solely for factual, scientifically oriented information about peptides. It does not constitute medical advice, does not replace a consultation with a doctor and contains no recommendations for use in humans.
This site does not sell any substances and names no sources for unapproved substances. For medical questions, please consult qualified medical professionals.